Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761
-
Avant Technologies and Ainnova Secure Advanced AI Algorithms for Early Detection of Four Additional Diseases in the U.S.
-
HERE Technologies brings AI-powered mapping and software-defined vehicle innovations to CES 2025 after milestone year
-
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Despite Organizations Scrambling to Adapt Following the 2024 Election, Nearly 90% of SMB Owners Surveyed Remain Optimistic for 2025
-
Avalyn to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Walrus Pump Announces Financial and Operating Results for Three Quarters of FY2024
-
WEBs Investments Inc. and Westwood Holdings Group Launch Defined Volatility℠ ETF Series with Debut of DVSP and DVQQ
-
Net Asset Value(s)
-
RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine
-
Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity
-
Copenhagen Infrastructure Partners acquires majority stake in ABO Energy’s wind and hydrogen project
-
USA Rare Earth Appoints Joshua Ballard as Chief Executive Officer
-
OFFER UPDATE – USE OF OVER-ALLOTMENT FACILITY
-
Wearable Devices and RayNeo Unveil First Neural-Controlled AR Glasses at CES 2025, Serving as the Catalyst for Strategic Collaborations and OEM Integrations
-
Demesne Resources Ltd. Confirms Underground Access to Tungsten Vein System, IMA Mine Project in Idaho, USA
-
Cartier Cuts 44.7 g/t Au over 0.5 m and 7.5 g/t Au over 4.6 m Extending to 10 km the High-Grade Gold Potential at East Cadillac
-
Prime Drink Group Announces Private Placement
-
VR Resources Completes Phase 1 Drilling at Empire Project in Ontario
-
Encouraging Initial Drilling Results Reported from the Pense Critical Metals Project
-
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium
-
AppTech Announces $5,000,000 Common Equity Raise and Board Member Changes
-
ZenaTech to Use Quantum Computing for Wildfire Tracking in the Western US; Part of a Third LOI for Land Survey Company Acquisition
-
Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024
-
Prairie Operating Co. To Host Year-End Update Call Highlighting Current Operations and Key Achievements in 2024
-
Red Pine Prospecting Program Discovers Additional Gold Mineralization Immediately West of the Existing Mineral Resource and Acquires Strategic Mining Claim
-
Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease
-
Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
-
REE Automotive Reports Q3 2024 Results: Reservations Surge by 230% as Production Begins and Liquidity Increases, Reaffirming BoM Breakeven Target for H2 2025
-
MINILUXE ANNOUNCES FRANCHISEE OPERATOR PARTNERSHIP
-
Form 8.3 - [LOUNGERS PLC - 16 12 2024] - (CGWL)
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 16 12 2024] - (CGWL)
-
Stardust Power Acquires Site, Receives Key Permit And Receives Approval For Major Construction To Commence
-
Wellpath Partners with Awell to Improve Quality of Care through Data-Driven Improvements
-
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
-
BexBack Launches Double Deposit Bonus, $50 Welcome Bonus and 100x Leverage Crypto Trading No KYC
-
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
-
Americold Realty Trust, Inc. Declares Fourth Quarter 2024 Dividend
-
Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive Bioequivalence Data in Clinical Therapeutics
-
American Shared Hospital Services Announces Official Notice of Certificate of Need Approval to Acquire the Technology to Construct and Operate a Proton Beam Radiation Therapy Facility in the State of
-
EyePoint to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
-
Gaming and Leisure Properties Completes Previously Announced $395 Million Sale Leaseback Transaction with Bally’s for Kansas City and Shreveport Properties
-
BioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product Family
-
Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
-
AOI Adds Kevin Jones to Lead Global Sales Team for Quantum Bandwidth™
-
Better Choice Company Provides Shareholder Update Regarding its Authorized Stock Repurchase Program
-
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
-
Mage Data™ Recognized as a Leader in Data Masking Solutions by QKS Group
-
Bunker Hill Mining Intersects High-Grade Zinc-Lead-Silver Mineralization Adjacent to Existing Underground Infrastructure
